The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment
- PMID:17046842
- PMCID: PMC1994509
- DOI: 10.1136/jcp.2006.043802
The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment
Abstract
Total mesorectal excision (TME) refers to the surgical removal of the complete perirectal soft tissue envelope, using sharp instruments under direct vision, and has become the contemporary standard of care for patients with rectal cancer. Pathologists play a key role in the evaluation of these specimens, including the quality assurance of surgical performance, as well as evaluation of the circumferential radial margin (CRM). While the latter is the most significant predictor of local recurrence, the quality of the excised mesorectum is another important factor in assessing the risk of local recurrence in patients with a negative CRM. Since proper pathological assessment of the TME specimen provides important prognostic information, as well as critical feedback to surgeons regarding technical performance, it is important to have adequate guidelines for the macroscopic handling of these specimens. The CLASSICC study of the Medical Research Council in the United Kingdom, as well as the Dutch TME trial have introduced a new standard for the pathological assessment of TME specimens, including an approach that involves assessment in both the fresh and fixed states, at least 48 hours of fixation of an intact specimen, with observations made on both the external appearance and cross-sectional slices. This article reviews the pathological assessment of the TME specimen, including basic definitions, current international guidelines, an approach to evaluating the mesorectum and a discussion of special issues relating to margins, lymph node retrieval and effects of neoadjuvant therapy.
Conflict of interest statement
Competing interests: None declared.
Similar articles
- Factors that influence the adequacy of total mesorectal excision for rectal cancer.Jeyarajah S, Sutton CD, Miller AS, Hemingway D; Leicester Colorectal Specialist Group.Jeyarajah S, et al.Colorectal Dis. 2007 Nov;9(9):808-15. doi: 10.1111/j.1463-1318.2007.01256.x. Epub 2007 Apr 18.Colorectal Dis. 2007.PMID:17441969
- Role of total mesorectal excision and of circumferential resection margin in local recurrence and survival of patients with rectal carcinoma.Tzardi M.Tzardi M.Dig Dis. 2007;25(1):51-5. doi: 10.1159/000099170.Dig Dis. 2007.PMID:17384508Review.
- [Parametric monitoring of the quality of total mesorectal excision and surgical treatment of rectal carcinoma results of a multicenter study].Hoch J, Ferko A, Bláha M, Ryška A, Čapov I, Dušek L, Feit J, Grega M, Hermanová M, Hovorková E, Chmelová R, Kala Z, Klos D, Kodet R, Langer D, Hadži-Nikolov D, Örhalmi J, Páral J, Tichý M, Tučková I, Vjaclovský M, Vlček P.Hoch J, et al.Rozhl Chir. 2016 Summer;95(7):262-71.Rozhl Chir. 2016.PMID:27523174Czech.
- Cancer of the upper rectum.Bondeven P.Bondeven P.Dan Med J. 2016 Oct;63(10):B5227.Dan Med J. 2016.PMID:27697137Review.
- Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL.Kusters M, et al.Eur J Surg Oncol. 2010 May;36(5):470-6. doi: 10.1016/j.ejso.2009.11.011. Epub 2010 Jan 21.Eur J Surg Oncol. 2010.PMID:20096534Clinical Trial.
Cited by
- A review of controversies in the management of colorectal cancers.Deo SV, Kapali AS, Gupta M, Shukla NK.Deo SV, et al.Indian J Surg. 2012 Jun;74(3):221-7. doi: 10.1007/s12262-012-0586-5.Indian J Surg. 2012.PMID:23730048Free PMC article.
- The Importance of the Pathologist's Role in Assessment of the Quality of the Mesorectum.Bosch SL, Nagtegaal ID.Bosch SL, et al.Curr Colorectal Cancer Rep. 2012 Jun;8(2):90-98. doi: 10.1007/s11888-012-0124-7. Epub 2012 Mar 27.Curr Colorectal Cancer Rep. 2012.PMID:22611342Free PMC article.
- Intraoperative pelvic neuromonitoring based on bioimpedance signals: a new method analyzed on 30 patients.Kalev G, Schuler R, Langer A, Goos M, Konschake M, Schiedeck T, Marquardt C.Kalev G, et al.Langenbecks Arch Surg. 2024 Aug 3;409(1):237. doi: 10.1007/s00423-024-03403-y.Langenbecks Arch Surg. 2024.PMID:39096391Free PMC article.
- Histopathological Analysis of 173 Consecutive Patients with Colorectal Carcinoma: A Pathologist's View.Canbey Göret C, Göret NE.Canbey Göret C, et al.Med Sci Monit. 2018 Sep 26;24:6809-6815. doi: 10.12659/MSM.911012.Med Sci Monit. 2018.PMID:30255856Free PMC article.
- Colorectal Cancer OncoGuia: surgical pathology report guidelines.Sanjuán X, Salas A, Lloreta J, Manchon Walsh P; Colorectal Cancer OncoGuia Group.Sanjuán X, et al.Clin Transl Oncol. 2010 Mar;12(3):211-3. doi: 10.1007/s12094-010-0490-z.Clin Transl Oncol. 2010.PMID:20231125No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources